1. Home
  2. PSQH vs CVM Comparison

PSQH vs CVM Comparison

Compare PSQH & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

N/A

Current Price

$6.34

Market Cap

29.3M

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

N/A

Current Price

$1.61

Market Cap

30.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSQH
CVM
Founded
2021
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
30.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
PSQH
CVM
Price
$6.34
$1.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
534.5K
198.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
55.00
N/A
EPS
N/A
N/A
Revenue
$5,685,987.00
$264,033.00
Revenue This Year
$80.20
N/A
Revenue Next Year
$34.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1096.61
65.45
52 Week Low
$0.36
$0.89
52 Week High
$6.94
$12.68

Technical Indicators

Market Signals
Indicator
PSQH
CVM
Relative Strength Index (RSI) 74.78 56.85
Support Level $0.61 $0.98
Resistance Level N/A $1.68
Average True Range (ATR) 0.64 0.12
MACD 0.19 -0.01
Stochastic Oscillator 94.85 54.08

Price Performance

Historical Comparison
PSQH
CVM

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: